Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease (original) (raw)
Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
Thomas Haggerty
PLoS ONE, 2011
View PDFchevron_right
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
Thomas Haggerty
BMC Neuroscience, 2011
View PDFchevron_right
-Synuclein contributes to GSK-3 -catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka
The FASEB Journal, 2009
View PDFchevron_right
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jessi Sidhu
Experimental Neurology, 2010
View PDFchevron_right
Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies
Esther Dalfo
Neuroscience, 2008
View PDFchevron_right
Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies
George Perry
Neurodegenerative Diseases, 2008
View PDFchevron_right
Leucine-Rich Repeat Kinase 2 Colocalizes with a-Synuclein in Parkinson's Disease, but Not Tau-Containing Deposits in Tauopathies
Shu Chen
Neurodegenerative …, 2008
View PDFchevron_right
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α-synuclein, and tau
Jean-Marc Taymans
Bioessays, 2010
View PDFchevron_right
Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies
Mark Smith
Neurodegenerative Diseases, 2008
View PDFchevron_right
NACP/α-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies
Abdul Alim
Acta Neuropathologica, 2000
View PDFchevron_right
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and -Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Hamid Yaqoob Qureshi
Journal of Biological Chemistry, 2011
View PDFchevron_right
Alpha-Synuclein Induces Hyperphosphorylation of Au in the Mptp Model of Parkinsonism
Tetyana Duka
The FASEB Journal, 2006
View PDFchevron_right
Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases
Kelly Del Tredici
Cold Spring Harbor Perspectives in Biology, 2016
View PDFchevron_right
The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
marianna selikhova
Neurodegenerative Diseases, 2013
View PDFchevron_right
Coevolution study of tau and a-synuclein suggests a connection between their normal interaction in neurons and the Parkinson's disease-associated mutation A53T
james gruschus
Medical Research Archives, 2021
View PDFchevron_right
alpha -Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356
Henrik Hager
Journal of Biological Chemistry, 1999
View PDFchevron_right
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
Tyrell Simkins
Cell death and differentiation, 2014
View PDFchevron_right
Loss of Tau Expression Attenuates Neurodegeneration Associated with α-Synucleinopathy
Balvindar Singh
Research Square (Research Square), 2021
View PDFchevron_right
Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
Rita Oliveira
PLoS ONE, 2011
View PDFchevron_right
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
Rosalia Dacosta Aguayo
Movement disorders : official journal of the Movement Disorder Society, 2017
View PDFchevron_right
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease
Akihiko Koyama
PloS one, 2011
View PDFchevron_right
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
Nicola Tambasco, Lucilla Parnetti, Omar El-agnaf, Lucia Farotti
Frontiers in Aging Neuroscience, 2014
View PDFchevron_right
Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia
Seth Love
Acta Neuropathologica, 1999
View PDFchevron_right
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Natalie Henson
Molecular Neurodegeneration
View PDFchevron_right
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
Alex Rajput
Neurology, 2006
View PDFchevron_right
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau
Tsutomu Hashikawa
The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002
View PDFchevron_right
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
Barbara Borroni
Movement Disorders, 2011
View PDFchevron_right
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Hans-wolfgang Klafki
Proceedings of the National Academy of Sciences of the United States of America, 2006
View PDFchevron_right